C57BL/6JCya-Slc17a9em1flox/Cya
Common Name
Slc17a9-flox
Product ID
S-CKO-07222
Backgroud
C57BL/6JCya
Strain ID
CKOCMP-228993-Slc17a9-B6J-VA
When using this mouse strain in a publication, please cite “Slc17a9-flox Mouse (Catalog S-CKO-07222) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
Basic Information
Strain Name
Slc17a9-flox
Strain ID
CKOCMP-228993-Slc17a9-B6J-VA
Gene Name
Product ID
S-CKO-07222
Gene Alias
Vnut, 1700019H03Rik
Background
C57BL/6JCya
NCBI ID
Modification
Conditional knockout
Chromosome
Chr 2
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000094218
NCBI RefSeq
NM_183161
Target Region
Exon 2~3
Size of Effective Region
~1.2 kb
Overview of Gene Research
Slc17a9, also known as VNUT (vesicular nucleotide transporter), is a transmembrane protein encoding a vesicular ATP transport protein. It functions in lysosomes and other secretory vesicles, playing a crucial role in maintaining lysosomal function and cell viability, and is involved in multiple biological processes. It has been associated with pathways like the PI3K/Akt signaling pathway [3].
In cancer research, Slc17a9 has shown significant implications. In clear cell renal cell carcinoma (ccRCC), its knockdown inhibited cancer cell proliferation, migration, and invasion, while overexpression promoted a more malignant phenotype both in vitro and in vivo. It was found to upregulate PTHLH, promoting epithelial-mesenchymal transition (EMT) in ccRCC [1]. In hepatocellular carcinoma (HCC), the HHEX-ABI2/Slc17a9 axis was shown to induce cancer stem cell-like properties and tumorigenesis [2]. Additionally, in non-small cell lung cancer (NSCLC), its up-regulation was correlated with survival, and knockdown significantly inhibited cell proliferation and ATP levels in lung cancer cells [5]. In gastric, colorectal cancers, high Slc17a9 expression was associated with poor survival, suggesting it could be a prognostic biomarker [4,8]. In osteoblasts, knockdown of Slc17a9 reduced extracellular ATP levels and led to increased osteoblast differentiation in response to compressive force [6]. In the context of heart-brain interaction during pressure overload, adrenergic neuron-specific knockout of Slc17a9 reduced cardiac extracellular ATP level, inhibited NLRP3 inflammasome activation, IL-1β production, and adaptive cardiac hypertrophy [7].
In conclusion, Slc17a9 is essential for maintaining cell viability through regulating lysosomal function. Its role in multiple cancer types, osteoblast differentiation, and cardiac inflammation and hypertrophy has been revealed through various gene-knockout and knockdown experiments. These findings suggest that Slc17a9 could be a potential therapeutic target and prognostic biomarker in related diseases.
References：
1. Li, Weiquan, Xu, Ning, Meng, Xiangui, Xiao, Wen, Zhang, Xiaoping. 2022. SLC17A9-PTHLH-EMT axis promotes proliferation and invasion of clear renal cell carcinoma. In iScience, 26, 105764. doi:10.1016/j.isci.2022.105764. https://pubmed.ncbi.nlm.nih.gov/36590170/
2. Li, Huizi, Liu, Jin, Lai, Jie, Zhang, Tong, Gu, Qiuping. 2024. The HHEX-ABI2/SLC17A9 axis induces cancer stem cell-like properties and tumorigenesis in HCC. In Journal of translational medicine, 22, 537. doi:10.1186/s12967-024-05324-2. https://pubmed.ncbi.nlm.nih.gov/38844969/
3. Kui, Xue-Yan, Gao, Yan, Liu, Xu-Sheng, Zhang, Yao-Hua, Pei, Zhi-Jun. 2022. Comprehensive Analysis of SLC17A9 and Its Prognostic Value in Hepatocellular Carcinoma. In Frontiers in oncology, 12, 809847. doi:10.3389/fonc.2022.809847. https://pubmed.ncbi.nlm.nih.gov/35957868/
4. Li, Junqing, Su, Taiqiang, Yang, Liang, Zhang, Changhua, He, Yulong. 2019. High SLC17A9 expression correlates with poor survival in gastric carcinoma. In Future oncology (London, England), 15, 4155-4166. doi:10.2217/fon-2019-0283. https://pubmed.ncbi.nlm.nih.gov/31799885/
5. Gao, Yan, Chen, Yijia, Liu, Min, Ke, Changbin, Pei, Zhijun. 2023. SLC17A9 as a prognostic biomarker correlated with immune infiltrates in human non-small cell lung cancer. In American journal of cancer research, 13, 3963-3982. doi:. https://pubmed.ncbi.nlm.nih.gov/37818081/
6. Inoue, Asako, Nakao-Kuroishi, Kayoko, Kometani-Gunjigake, Kaori, Kokabu, Shoichiro, Kawamoto, Tatsuo. 2020. VNUT/SLC17A9, a vesicular nucleotide transporter, regulates osteoblast differentiation. In FEBS open bio, 10, 1612-1623. doi:10.1002/2211-5463.12918. https://pubmed.ncbi.nlm.nih.gov/32592329/
7. Higashikuni, Yasutomi, Liu, Wenhao, Numata, Genri, Komuro, Issei, Sata, Masataka. 2022. NLRP3 Inflammasome Activation Through Heart-Brain Interaction Initiates Cardiac Inflammation and Hypertrophy During Pressure Overload. In Circulation, 147, 338-355. doi:10.1161/CIRCULATIONAHA.122.060860. https://pubmed.ncbi.nlm.nih.gov/36440584/
8. Yang, Liang, Chen, Zhihui, Xiong, Weixin, Song, Xinming, Liu, Jia. 2018. High expression of SLC17A9 correlates with poor prognosis in colorectal cancer. In Human pathology, 84, 62-70. doi:10.1016/j.humpath.2018.09.002. https://pubmed.ncbi.nlm.nih.gov/30236596/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.